Fetal and maternal thyroid function are working independently under ph
ysiologic conditions. In case of maternal autoimmune hyperthyroidism d
uring pregnancy there is an up to 12% chance for the fetus to develop
thyroid dysfunction, mediated by the transplacental passage of materna
l immunoglobulins directed against TSH receptors in the fetal thyroid
gland. This may lead to intrauterine growth retardation, craniosynosto
sis, preterm delivery, perinatal death, etc. Sonography and fetal bloo
d sampling provide important information to detect fetuses at risk and
allow intrauterine therapy. Furthermore prenatal diagnosis is importa
nt in case of maternal antithyroid drug ingestion possibly leading to
fetal hypothyroidism and goitre. The cooperation of specialists for in
ternal and fetal medicine is required for the management of maternal t
hyroid disease in pregnancy.